MetLife (MET) Stock Price, News & Analysis

Company Overview

MetLife, Inc. is a leading global provider of insurance, annuities and employee benefit programs, serving individuals and institutions in more than 40 countries. Headquartered in New York City, MetLife was founded in 1868 as the National Union Life and Limb Insurance Company and later adopted its current name in 1869. Over the course of more than 150 years, the company has grown to become one of the largest life insurers in the United States and a significant presence in key international markets.

The company’s core product offerings include individual life insurance, annuities and retirement savings solutions designed to help clients manage long-term financial security. MetLife also offers group benefits products—such as dental, vision, disability and supplemental health insurance—to employers seeking to provide comprehensive coverage to their workforces. In addition, MetLife provides asset management and institutional funding solutions for pension plans, endowments and other large-scale investors through its affiliate, MetLife Investment Management.

Through a network of affiliates and distribution partners, MetLife operates in North America, Latin America, Asia, Europe and the Middle East. The company has established a strong presence in fast-growing markets in Latin America and Asia, with operations in Japan, the Philippines, India and Brazil, among others. In the United States, MetLife serves individuals and small businesses through retail agents and digital channels, while its group benefits business works directly with corporations and nonprofit organizations.

MetLife completed its initial public offering in April 2000, transitioning from a mutual company to a publicly traded corporation listed on the New York Stock Exchange under the ticker symbol MET. The company’s leadership team is headed by President and Chief Executive Officer Michel Khalaf, who was appointed in 2021. Under his direction, MetLife continues to focus on digital innovation, operational efficiency and strategic partnerships to drive growth and enhance customer experiences globally.

Key Stats

• Today's Range: $79.69 to $80.96
• 50-Day Range: $73.78 to $81.42
• 52-Week Range: $65.21 to $89.05
• Volume: 86,820 shs
• Average Volume: 3.36 million shs
• Market Capitalization: $53.15 billion
• P/E Ratio: 13.53
• Dividend Yield: 2.84%
• Price Target: $95.60
• Consensus Rating: Moderate Buy

MetLife Stock Analysis - MarketRank™

MetLife scored higher than 100% of companies evaluated by MarketBeat, and ranked 2nd out of 930 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

MetLife has received a consensus rating of Moderate Buy. The company's average rating score is 2.91, and is based on 10 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

MetLife has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 9.53%

Earnings Growth

Earnings for MetLife are expected to grow by 9.53% in the coming year, from $9.65 to $10.57 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of MetLife is 13.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 269.63.

Price to Earnings Ratio vs. Sector

The P/E ratio of MetLife is 13.80, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 229.01.

Price to Earnings Growth Ratio

MetLife has a PEG Ratio of 0.73. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

MetLife has a P/B Ratio of 2.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.33% of the float of MetLife has been sold short.

Short Interest Ratio / Days to Cover

MetLife has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MetLife has recently decreased by 7.81%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

MetLife pays a meaningful dividend of 2.79%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

MetLife has been increasing its dividend for 12 years.

Dividend Coverage

The dividend payout ratio of MetLife is 38.47%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, MetLife will have a dividend payout ratio of 21.48% next year. This indicates that MetLife will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.0 / 5
• Environmental Score: -0.75

Percentage of Shares Shorted

1.33% of the float of MetLife has been sold short.

Short Interest Ratio / Days to Cover

MetLife has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MetLife has recently decreased by 7.81%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.77

News Sentiment

MetLife has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.24 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 33 news articles for MetLife this week, compared to 37 articles on an average week.

Search Interest

27 people have searched for MET on MarketBeat in the last 30 days. This is an increase of 4% compared to the previous 30 days.

MarketBeat Follows

11 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is an increase of 57% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MetLife insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.35% of the stock of MetLife is held by insiders.

Percentage Held by Institutions

94.99% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MET Stock Analysis - Frequently Asked Questions

How have MET shares performed this year?

MetLife's stock was trading at $81.88 on January 1st, 2025. Since then, MET shares have decreased by 0.6% and is now trading at $81.4080.

How were MetLife's earnings last quarter?

MetLife, Inc. (NYSE:MET) issued its earnings results on Wednesday, August, 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing analysts' consensus estimates of $2.32 by $0.30. The firm's revenue for the quarter was down 2.7% on a year-over-year basis.
Read the conference call transcript.

Is MetLife doing a stock buyback?

MetLife's board authorized a share buyback program on Wednesday, April 30th 2025, which authorizes the company to buy back $3,000,000,000 in shares, according to EventVestor. This means that the company could purchase up to 5.9% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

Does MetLife have any subsidiaries?

MetLife subsidiaries include these companies: Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and more.

Who are MetLife's major shareholders?

Top institutional shareholders of MetLife include Vanguard Group Inc. (8.52%), Dodge & Cox (8.00%), State Street Corp (3.91%) and Geode Capital Management LLC (1.91%). Insiders that own company stock include Steven J Goulart, Ramy Tadros, Marlene Debel, Bill Pappas, Susan M Podlogar and Jeh C Johnson.
View institutional ownership trends.

How do I buy shares of MetLife?

Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of MetLife own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Exxon Mobil (XOM), Salesforce (CRM) and Verizon Communications (VZ).

Company Calendar

• Record date for 6/10 Dividend: 5/06/2025
• Ex-Dividend for 6/10 Dividend: 5/06/2025
• Dividend Payable: 6/10/2025
• Record date for 9/9 Dividend: 8/05/2025
• Ex-Dividend for 9/9 Dividend: 8/05/2025
• Last Earnings: 8/06/2025
• Today: 9/02/2025
• Dividend Payable: 9/09/2025
• Next Earnings (Estimated): 10/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: INS - MULTI LINE
• Sub-Industry: Life & Health Insurance
• Current Symbol: NYSE:MET
• CIK: 1099219
• Web: www.metlife.com
• Phone: (212) 578-9500
• Fax: 212-578-3320
• Employees: 45,000
• Year Founded: 1868

Price Target and Rating

• Average Price Target for MetLife: $95.60
• High Price Target: $103.00
• Low Price Target: $91.00
• Potential Upside/Downside: +17.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.91
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $5.90
• Trailing P/E Ratio: 13.80
• Forward P/E Ratio: 8.44
• P/E Growth: 0.73
• Net Income: $4.43 billion
• Net Margins: 5.83%
• Pretax Margin: 7.82%
• Return on Equity: 19.88%
• Return on Assets: 0.82%

Debt

• Debt-to-Equity Ratio: 0.57
• Current Ratio: 0.16
• Quick Ratio: 0.16

Sales & Book Value

• Annual Sales: $70.99 billion
• Price / Sales: 0.76
• Cash Flow: $7.19 per share
• Price / Cash Flow: 11.33
• Book Value: $40.01 per share
• Price / Book: 2.03

Miscellaneous

• Outstanding Shares: 665,030,000
• Free Float: 662,698,000
• Market Cap: $54.14 billion
• Optionable: Optionable
• Beta: 0.87